Skip to main content
SOLESENCE, INC. logo

SOLESENCE, INC. — Investor Relations & Filings

Ticker · SLSN ISIN · US6300791018 US Manufacturing
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2014-11-25 Director's Dealing
Country US United States of America
Listing US SLSN

About SOLESENCE, INC.

https://ir.solesence.com/

Solesence, Inc. is a developer and manufacturer specializing in mineral-based skincare and color cosmetics for partner brands. The company focuses on skin health through its proprietary and patented technologies, including the Active Stress Defense™ suite and Solésence Kleair™. These technologies are engineered to create highly effective, transparent, and aesthetically pleasing mineral sun protection (SPF) products. Solesence enables the creation of innovative textures and formats in skincare, sun care, and color cosmetics, offering both contract manufacturing and white-label product solutions to the beauty industry.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2014-11-25 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 25, 2014, reporting an event that occurred on November 19, 2014. The content describes the entry into a material definitive agreement, specifically an amendment to a supply agreement between Nanophase Technologies Corporation and Roche Diagnostics GmbH. There are no financial statements or earnings data presented, nor is this a report of annual or quarterly results. The document is an announcement of a significant contract amendment, which fits the category of Capital/Financing Update (CAP) as it relates to material agreements affecting the company's business and potentially its financial position. The document length is under 5,000 characters and contains substantive information about the agreement, not just a notice of report publication or certification. Therefore, the best classification is CAP with high confidence.
2014-11-25 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically reports the departure of a senior officer, Dr. Pat Murray, the Vice President of Research and Development, and the interim management arrangement. This matches the description of announcements related to changes in the company's board of directors or senior management. The document is not a full annual or quarterly report, nor is it an earnings release or other financial report. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on management change, confirming this classification with high confidence.
2014-11-25 English
FORM 4 SUBMISSION
Director's Dealing
2014-11-21 English
10-Q
Interim / Quarterly Report 9M 2014
2014-11-12 English
FORM 8-K FILING DOCUMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing, which is a current report filed with the SEC to announce major events that shareholders should know about. The text includes a reference to Item 2.02 "Results of Operations and Financial Condition" and mentions a press release attached as Exhibit 99.1. The document itself does not contain detailed financial statements or comprehensive financial data but rather references a press release. The length is only 2572 characters, which is short and consistent with a brief announcement rather than a full financial report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full financial report or detailed financial data itself.
2014-11-04 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.